The world’s first vaccine to treat deadly cancerous brain tumors can potentially give patients years of extra life, a global clinical trial from Maryland’s Northwest Biotherapeutics has concluded.
Vaccine prolongs life of patients with aggressive brain cancer in new trial Read more
The country’s maternal mortality ratio (MMR) witnessed a decline by 6 points at 97 per lakh live births in 2018-2020, from 130 in 2014-16.
India’s maternal mortality ratio declines 25% between 2016 and 2020 Read more
The federal carbon price floor was a charge of CAN$40 per ton on carbon emissions in 2021, and this fee will rise to CAN$170 per ton by 2030.
Canada expands its pollution pricing rules Read more
Researchers have seen successful results in sheep with minimal side effects. They are now preparing for its first-ever human clinical trial to be conducted in Melbourne.
In a 7-5 vote, council members approved legislation to create a partnership between the city and a nonprofit group called RIP Medical Debt to relieve debt for eligible Toledo residents.
Toledo City Council approves medical debt relief legislation Read more
According to a recent study for estimating the prevalence of blindness and visual impairment in the Indian population, more than one fourth of people in India aged 50 years and above are visually impaired.
Cases of blindness and visual impairment in India have declined by roughly 50% since 2010 Read more
Demand for blood donations currently far outstrips supply and matching blood types is an extra hassle that often results in patients missing out even as donated blood goes to waste.
First human patients receive transfusions of lab-grown blood cells Read more
The age-adjusted prevalence of dementia declined from 12.2 percent of people over age 65 in 2000 to 8.5 percent of people over age 65 in 2016—a nearly one-third drop from the 2000 level, according to a new RAND Corporation study.
Prevalence of dementia is declining among older Americans Read more
The study found that after ten years 80% of patients were still alive. Typically, only roughly 50% of people in similar conditions would be expected to survive over that span.
Groundbreaking experimental breast cancer vaccine passes first human trials Read more
Maternal vaccination reduced rates of severe medically attended lower respiratory tract illness due to RSV by 81.8% across the first three months of life.
“Remarkable” results for new maternal RSV vaccine in Phase 3 trial Read more
